Four-meter gait speed (4MGS) has been associated with functional capacity and overall mortality in elderly patients, and may easily be translated to daily practice. We evaluated the association of 4MGS with meaningful outcomes.
METHODS:
In 70 subjects we conducted the 4MGS, 6-min walk test (6MWT), objectively measured physical activity, and assessed dyspnea, quality of life, and self-efficacy for walking and routine physical activity. 4MGS was measured in 3 separate time epochs during the 6MWT, to explore 4MGS variability.
RESULTS:
Diagnoses included COPD (51.4%), interstitial lung disease (38.6%), and other pulmonary conditions (10%). The mean ± SD values were: 4MGS 0.85 ± 0.21 m/s, 6-min walk distance (6MWD) 305 ± 115 m, and physical activity level 1.28 ± 0.17, which is consistent with severe physical inactivity. The gait speeds within the time epochs 1–2, 3–4, and 5–6 min during the 6MWT were not significantly different: 1.01 ± 0.29 m/s, 0.98 ± 0.31 m/s, and 1.00 ± 0.31 m/s, respectively. 4MGS had a significant correlation with 6MWD (r = 0.70, P < .001). 6MWD was the dominant variable for predicting 4MGS. Other significant predictors of 4MGS included dyspnea, self-efficacy, quality of life, and objectively measured physical activity.
CONCLUSIONS:
4MGS is significantly and independently associated with 6MWD, and may serve as a reasonable simple surrogate for 6MWD in subjects with chronic lung disease. Gait speed was remarkably stable throughout the 6MWT, which supports the validity of an abbreviated walk test such as 4MGS.
Abellan Van KanG, RollandY, AndrieuS, BauerJ, BeauchetO, BonnefoyM, et al. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) task force. J Nutr Health Aging, 2009; 13(10):881-889.
2.
BuchnerD, LarsonE, WagnerE, KoepsellT, De LateurB. Evidence for a non-linear relationship between leg strength and gait speed. Age Ageing, 1996; 25(5):386-391.
3.
DumurgierJ, ElbazA, DucimetiereP, TavernierB, AlperovitchA, TzourioC. Slow walking speed and cardiovascular death in well functioning older adults: prospective cohort study. BMJ, 2009; 339:b4460.
4.
GuralnikJ, FerrucciL, SimonsickE, SaliveM, WallaceR. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med, 1995; 332(9):556-561.
5.
PereraS, ModyS, WoodmanR, StudenskiS. Meaningful change and responsiveness in common physical performance measures in older adults. J Am Geriatr Soc, 2006; 54(5):743-749.
6.
SteffenT, HackerT, MollingerL. Age- and gender-related test performance in community-dwelling elderly people: Six-Minute Walk Test, Berg Balance Scale, Timed Up & Go Test, and gait speeds. Phys Ther, 2002; 82(2):128-137.
7.
StudenskiS, PereraS, PatelK, RosanoC, FaulknerK, InzitariM, et al. Gait speed and survival in older adults. JAMA, 2011; 305(1):50-58.
8.
StudenskiS, PereraS, WallaceD, ChandlerJ, DuncanP, RooneyE, et al. Physical performance measures in the clinical setting. J Am Geriatr Soc, 2003; 51(3):314-322.
9.
ButcherSJ, MeshkeJM, SheppardMS. Reductions in functional balance, coordination, and mobility measures among patients with stable chronic obstructive pulmonary disease. J Cardiopulm Rehabil, 2004; 24(4):274-280.
10.
IlginD, OzalevliS, KilincO, SevincC, CimrinA, UcanE. Gait speed as a functional capacity indicator in patients with chronic obstructive pulmonary disease. Ann Thoracic Med, 2011; 6(3):141-146.
11.
KonSS, PatelMS, CanavanJL, ClarkAL, JonesSE, NolanCM, et al. Reliability and validity of the four metre gait speed in COPD. Eur Respir J, 2013; 42(2):333-340.
12.
BenzoR. Factors to inform clinicians about end of life in severe COPD. J Pain Symptom Manage, 2013; 46(4):491-499.e4.
13.
KongsgaardM, BackerV, JorgensenK, KjaerM, BeyerN. Heavy resistance training increases muscle size, strength and physical function in elderly male COPD-patients: a pilot study. Respir Med, 2004; 98(10):1000-1007.
14.
PolkeyMI, SpruitMA, EdwardsLD, WatkinsML, Pinto-PlataV, VestboJ, et al. Six minute walk test in COPD: minimal clinically important difference for death or hospitalization. Am J Respir Crit Care Med, 2013; 187(4):382-386.
15.
FritzS, LusardiM. White paper: “walking speed: the sixth vital sign”. J Geriatr Phys Ther, 2009; 32(2):2-5.
16.
StudenskiS. Bradypedia: is gait speed ready for clinical use?. J Nutr Health Aging, 2009; 13(10):878-880.
17.
BlanchardCM, FortierM, SweetS, O'SullivanT, HoggW, ReidRD, et al. Explaining physical activity levels from a self-efficacy perspective: the physical activity counseling trial. Ann Behav Med, 2007; 34(3):323-328.
18.
KaplanRM, AtkinsCJ, ReinschS. Specific efficacy expectations mediate exercise compliance in patients with COPD. Health Psychol, 1984; 3(3):223-242.
19.
KimC, McEwenLN, KiefferEC, HermanWH, PietteJD. Self-efficacy, social support, and associations with physical activity and body mass index among women with histories of gestational diabetes mellitus. Diabetes Educ, 2008; 34(4):719-728.
20.
RodgersWM, SullivanMJL. Task, coping, and scheduling self-efficacy in relation to frequency of physical activity. J Appl Soc Psychol, 2001; 31(4):741-753.
21.
BestallJC, PaulEA, GarrodR, GarnhamR, JonesPW, WedzichaJA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax, 1999; 54(7):581-586.
22.
BretscherM, RummansT, SloanJ, KaurJ, BartlettA, BorkenhagenL, et al. Quality of life in hospice patients: a pilot study. Psychosomatics, 1999; 40(4):309-313.
23.
BrownPD, MaurerMJ, RummansTA, PollockBE, BallmanKV, SloanJA, et al. A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival. Neurosurg, 2005; 57(3):495-503.
24.
LockeDE, DeckerPA, SloanJA, BrownPD, MalecJF, ClarkMM, et al. Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patients. J Pain Symptom Manage, 2007; 34(6):628-638.
25.
SpitzerWO, DobsonAJ, HallJ. Measuring the quality of life of cancer patients. A concise QL-index for use by physicians. J Chron Dis, 1981; 34(12):585-597.
26.
MillerMR, HankinsonJ, BrusascoV, BurgosF, CasaburiR, CoatesA, et al. Standardisation of spirometry. Eur Respir J, 2005; 26(2):319-338.
27.
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med, 2002; 166(1):111-117.
28.
HillK, DolmageTE, WoonL, GoldsteinR, BrooksD. Measurement properties of the SenseWear armband in adults with chronic obstructive pulmonary disease. Thorax, 2010; 65(6):486-491.
29.
PatelSA, BenzoRP, SlivkaWA, SciurbaFC. Activity monitoring and energy expenditure in COPD patients: a validation study. J COPD, 2007; 4(2):107-112.
30.
WatzH, WaschkiB, BoehmeC, ClaussenM, MeyerT, MagnussenH. Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med, 2008; 177(7):743-751.
31.
EnrightPL, SherrillDL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med, 1998; 158(5 Pt 1):1384-1387.
CaminatiA, BianchiA, CassandroR, Rosa MirendaM, HarariS. Walking distance on 6-MWT is a prognostic factor in idiopathic pulmonary fibrosis. Respir Med, 2009; 103(1):117-123.
34.
ChangJ, CurtisJ, PatrickD, RaghuG. Assessment of health-related quality of life in patients with interstitial lung disease. Chest, 1999; 116(5):1175-1182.
35.
CoteC, Pinto-PlataV, KasprzykK, DordellyL, CelliB. The 6-min walk distance, peak oxygen uptake, and mortality in COPD. Chest, 2007; 132(6):1778-1785.
36.
KawutS, O'SheaM, BartelsM, WiltJ, SonettJ, ArcasoyS. Exercise testing determines survival in patients with diffuse parenchymal lung disease evaluated for lung transplantation. Respir Med, 2005; 99(11):1431-1439.
37.
MiyamotoS, NagayaN, SatohT, KyotaniS, SakamakiF, FujitaM, et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med, 2000; 161(2 Pt 1):487-492.
38.
OgaT, NishimuraK, TsukinoM, HajiroT, IkedaA, MishimaM. Relationship between different indices of exercise capacity and clinical measures in patients with chronic obstructive pulmonary disease. Heart Lung, 2002; 31(5):374-381.
39.
TaichmanDB, ShinJ, HudL, Archer-ChickoC, KaplanS, SagerJS, et al. Health-related quality of life in patients with pulmonary arterial hypertension. Respir Res, 2005; 6:92. DOI: 10.1186/1465-9921-6-92.
40.
WaschkiB, KirstenA, HolzO, MullerKC, MeyerT, WatzH, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest, 2011; 140(2):331-342.
41.
LeungA, ChanK, SykesK. Reliability, validity, and responsiveness of a 2-min walk test to assess exercise capacity of COPD patients. Chest, 2006; 130(1):119-125.
